Project Grant HT94252510875
- The University of Alabama at Birmingham (UAB) was awarded a $733,662 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2024, supports research to investigate the role of tumor glycans in immune suppression. This federally funded project aims to advance scientific understanding of how specific carbohydrate molecules on tumor cells can inhibit the body's immune response, with the goal of...
- The University of Alabama at Birmingham (UAB) was awarded a $220,326 Project Grant under the Military Medical Research and Development (CFDA 12.420) program by the Defense Health Agency. The award, with a performance period from April 1, 2025 to March 31, 2027, will fund the development of novel, selective PARP protein degraders for prostate cancer treatment, leveraging enhanced PSMA uptake. This research aims to transform healthcare for military service members, veterans, and the broader public...
- The University of Alabama at Birmingham (UAB) received a $1,599,981.00 Project Grant award from the Defense Health Agency on June 1, 2024 under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to activate immune reserves and prevent secondary bacterial lung infections after trauma and hemorrhage. This biomedical research project aims to improve health outcomes for military service members and the broader public. The project will be conducted over a...
- The University of Alabama at Birmingham (UAB) was awarded a $2,069,849 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The award will support UAB's research from May 1, 2023 to April 30, 2027 to understand cardiovascular disease in mental health and stress disorders. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research,...
- The University of Alabama at Birmingham (UAB) has been awarded a $297,000 Project Grant from the Department of Defense's Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This grant, awarded on August 1, 2024, will fund research to evaluate the role of Notch signaling in chronic pancreatitis. As a leading research institution, UAB will leverage its expertise in biomedical research to advance scientific understanding and potentially improve treatment...
- The University of Alabama at Birmingham was awarded a $1,485,001.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "OVERCOMING PERTURBATIONS THAT ORCHESTRATE IMMUNE EXHAUSTION AND DYSFUNCTION IN BREAST CANCER", supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The funding will enable the university to conduct...
- The University of Alabama at Birmingham (UAB) was awarded a $1,485,000.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to improve the oncolytic immunovirotherapy of malignant glioma by targeting the glioma secretome. The 3-year grant was awarded on September 30, 2023 and is set to conclude on September 29, 2026. UAB is a public research university known for its innovative and interdisciplinary approach to education, and it...
- The University of Alabama at Birmingham (UAB) was awarded a $2,119,086 Project Grant by the Defense Health Agency (DHA) under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on the Hedgehog pathway in chronic pancreatitis. The 4-year grant, which began on September 30, 2023, aims to advance scientific understanding and develop new therapeutic approaches for this health condition affecting military service members and veterans....
- The University of Alabama at Birmingham (UAB) was awarded a $907,805 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year award beginning April 15, 2022 will support research entitled "Elevated Uracil Glycosylase Coupled to Reduced Base Excision Repair Promotes AA PCA Progression." Per the grant details, UAB will investigate how specific DNA repair mechanisms may promote the progression...
- The University of Alabama at Birmingham (UAB) received a $1,139,184.00 Project Grant award from the Defense Health Agency for the research project "MORE EFFECTIVE, KEEPING IT SAFE: REPEAT OHSV TREATMENT FOR GLIOMA". The award, which began on August 15, 2023 and is scheduled for completion on August 14, 2027, is funded through the Military Medical Research and Development program (CFDA 12.420). This grant supports UAB's biomedical research efforts to transform health care for Service...
The University of Alabama at Birmingham (UAB) was awarded a $148,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the funding will be used to investigate "The Polyol Pathway Promotes Renal Cancer Tumorigenesis Via Glucose-Mediated Lipogenesis". This project, to be conducted at the UAB campus in Birmingham, AL, is expected to run from October 1, 2025 to September 30, 2026. The Military Medical Research and Development program provides funding for innovative research across various medical disciplines, focusing on solutions to critical health challenges relevant to the military.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $148.5k | 8/6/25 |